Coverage
Filings
| Filing | Date |
|---|---|
| 224,000 Orion A-shares converted into B- | 22 Oct 2003 |
| Orion?s Simdax will wait for the final s | 2 Oct 2003 |
| Noiro deal closed | 1 Oct 2003 |
| 150,000 Orion A-shares converted into B- | 10 Sept 2003 |
| *CONVERSION OF A-SHARE INTO B-SHARE: ORI | 10 Sept 2003 |
| CapMan to acquire cosmetics unit Noiro f | 4 Sept 2003 |
| Orion Group Interim Report 1-6/2003 | 6 Aug 2003 |
| *CONVERSION OF A-SHARE INTO B-SHARE: ORI | 1 Aug 2003 |
Orion's collaboration partner Bayer announced U.S. FDA approval for darolutamide, an androgen receptor inhibitor (ARi), for metastatic hormone-sensitive prostate cancer (mHSPC).
| 100,000 ORION A-SHARES CONVERTED INTO B- |
| 1 Aug 2003 |
| Orion Pharma?s co-determination process | 17 Jul 2003 |
| Review in Germany for Orion Pharma´s lev | 10 Jul 2003 |
| 300 ORION A-SHARES CONVERTED INTO B-SHAR | 7 Jul 2003 |